Treat EGFR mutated Non small cell lung cancer with Moboxen 40mg Capsule

Globans Pharma
Globans Pharma
on February 05 2026 at 11:26 AM
It is a prescription based anticancer medicine. It comprises Mobocertinib, a tyrosine kinase inhibitor. Moboxen 40mg Capsule used to treat Non small cell lung cancer (NSCLC) with specific EFGR gene mutation. It effectively controls the spread of cancer. Always take it under strict medical supervision. Must visits the site of Globans Pharma to know the price details.
Viewing 0 replies - 0 through 0 (of 0 total)
No more results found
Viewing 0 replies - 0 through 0 (of 0 total)

Login or register to post your reply